SG149867A1 - Selective estrogen receptor modulators for the treatment of vasomotor symptoms - Google Patents
Selective estrogen receptor modulators for the treatment of vasomotor symptomsInfo
- Publication number
- SG149867A1 SG149867A1 SG200900414-4A SG2009004144A SG149867A1 SG 149867 A1 SG149867 A1 SG 149867A1 SG 2009004144 A SG2009004144 A SG 2009004144A SG 149867 A1 SG149867 A1 SG 149867A1
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- estrogen receptor
- receptor modulators
- selective estrogen
- vasomotor symptoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53844204P | 2004-01-22 | 2004-01-22 | |
US53834204P | 2004-01-22 | 2004-01-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG149867A1 true SG149867A1 (en) | 2009-02-27 |
Family
ID=34830456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200900414-4A SG149867A1 (en) | 2004-01-22 | 2005-01-18 | Selective estrogen receptor modulators for the treatment of vasomotor symptoms |
Country Status (20)
Country | Link |
---|---|
US (2) | US20090023917A1 (sl) |
EP (1) | EP1709021B1 (sl) |
JP (1) | JP4909086B2 (sl) |
KR (2) | KR101008804B1 (sl) |
CN (1) | CN102250042A (sl) |
AT (1) | ATE476428T1 (sl) |
AU (1) | AU2005207821B2 (sl) |
BR (1) | BRPI0506721A (sl) |
CA (1) | CA2551956C (sl) |
CR (1) | CR8517A (sl) |
DE (1) | DE602005022673D1 (sl) |
EA (2) | EA012262B1 (sl) |
EC (1) | ECSP066711A (sl) |
ES (1) | ES2347973T3 (sl) |
IL (1) | IL176738A0 (sl) |
MA (1) | MA28436B1 (sl) |
NO (1) | NO20063760L (sl) |
SG (1) | SG149867A1 (sl) |
UA (1) | UA85862C2 (sl) |
WO (1) | WO2005073204A1 (sl) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8933130B2 (en) | 2006-06-23 | 2015-01-13 | Radius Health, Inc. | Treatment of vasomotor symptoms with selective estrogen receptor modulators |
US10144736B2 (en) * | 2006-07-20 | 2018-12-04 | Gilead Sciences, Inc. | Substituted pteridines useful for the treatment and prevention of viral infections |
MX2011003383A (es) * | 2008-09-29 | 2011-04-21 | Lilly Co Eli | Modulador selectivo del receptor de estrogeno para el tratamiento de osteoartritis. |
US20100087402A1 (en) * | 2008-09-29 | 2010-04-08 | Vivus, Inc. | Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders |
US20100317635A1 (en) * | 2009-06-16 | 2010-12-16 | Endorecherche, Inc. | Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
LT2568806T (lt) | 2010-05-12 | 2016-09-26 | Radius Health, Inc. | Terapiniai režimai |
WO2012047617A1 (en) | 2010-09-28 | 2012-04-12 | Radius Health, Inc. | Selective androgen receptor modulators |
FR3014437B1 (fr) * | 2013-12-05 | 2016-12-23 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
FR3014434B1 (fr) * | 2013-12-05 | 2015-12-25 | Servier Lab | Nouveau procede de synthese du 7-methoxy-naphtalene-1-carbaldehyde et application a la synthese de l'agomelatine |
EP3834824A1 (en) | 2014-03-28 | 2021-06-16 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
KR101756050B1 (ko) | 2015-03-04 | 2017-07-07 | 길리애드 사이언시즈, 인코포레이티드 | 톨 유사 수용체 조정제 화합물 |
HRP20220619T1 (hr) | 2016-06-22 | 2023-02-03 | Ellipses Pharma Ltd | Postupci za liječenje ar+ raka dojke |
ES2826748T3 (es) | 2016-09-02 | 2021-05-19 | Gilead Sciences Inc | Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll |
AU2017318601B2 (en) | 2016-09-02 | 2020-09-03 | Gilead Sciences, Inc. | Toll like receptor modulator compounds |
US10385008B2 (en) | 2017-01-05 | 2019-08-20 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD1901-2HCL |
CN108675999B (zh) * | 2018-05-09 | 2021-03-16 | 浙江农林大学暨阳学院 | 一种醋酸铜催化制备8-(9-亚砜基-10-二氢菲)喹啉类化合物的方法 |
AU2019297421A1 (en) | 2018-07-04 | 2021-01-28 | Radius Pharmaceuticals, Inc. | Polymorphic forms of RAD 1901-2HCL |
KR102577142B1 (ko) | 2018-07-12 | 2023-09-12 | 일라이 릴리 앤드 캄파니 | 선택적 에스트로겐 수용체 분해제 |
TWI702219B (zh) * | 2018-07-12 | 2020-08-21 | 美商美國禮來大藥廠 | 選擇性雌激素受體降解劑 |
TWI751516B (zh) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
TW202212339A (zh) | 2019-04-17 | 2022-04-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
TW202115056A (zh) | 2019-06-28 | 2021-04-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑化合物的製備方法 |
TW202300492A (zh) | 2021-03-16 | 2023-01-01 | 美商美國禮來大藥廠 | 選擇性雌激素受體降解劑 |
WO2023150056A1 (en) | 2022-02-01 | 2023-08-10 | Eli Lilly And Company | Processes for the preparation of selective estrogen receptor degraders |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5998401A (en) * | 1995-02-28 | 1999-12-07 | Eli Lilly And Company | Naphthyl compounds, intermediates, compositions, and methods |
US5726186A (en) * | 1995-09-08 | 1998-03-10 | Eli Lilly And Company | Pentacyclic compounds, intermediates, processes, compositions, and methods |
ID19392A (id) * | 1996-08-29 | 1998-07-09 | Lilly Co Eli | Senyawa naftil dan bahan pertengahan serta komposisi dan metode penggunaan |
CA2213810C (en) * | 1996-08-29 | 2006-06-06 | Lewis Dale Pennington | Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods |
US5916916A (en) * | 1996-10-10 | 1999-06-29 | Eli Lilly And Company | 1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods |
CA2217810A1 (en) * | 1996-10-10 | 1998-04-10 | Eli Lilly And Company | 2-aryl-3-aminoaryloxynaphthyl compounds, intermediates, compositions and methods |
ATE295834T1 (de) * | 1997-08-07 | 2005-06-15 | Lilly Co Eli | 1-(4-substituierte alkoxy)benzylnaphthalinderivate als östrogeninhibitoren |
EA008024B1 (ru) * | 2002-07-22 | 2007-02-27 | Эли Лилли Энд Компани | Селективные модуляторы эстрогенных рецепторов, содержащие фенилсульфонильную группу |
-
2005
- 2005-01-18 UA UAA200607867A patent/UA85862C2/uk unknown
- 2005-01-18 US US10/597,241 patent/US20090023917A1/en not_active Abandoned
- 2005-01-18 ES ES05704874T patent/ES2347973T3/es active Active
- 2005-01-18 EP EP05704874A patent/EP1709021B1/en active Active
- 2005-01-18 DE DE602005022673T patent/DE602005022673D1/de active Active
- 2005-01-18 BR BRPI0506721-9A patent/BRPI0506721A/pt not_active IP Right Cessation
- 2005-01-18 EA EA200601353A patent/EA012262B1/ru not_active IP Right Cessation
- 2005-01-18 CA CA2551956A patent/CA2551956C/en not_active Expired - Fee Related
- 2005-01-18 SG SG200900414-4A patent/SG149867A1/en unknown
- 2005-01-18 AT AT05704874T patent/ATE476428T1/de not_active IP Right Cessation
- 2005-01-18 WO PCT/US2005/000020 patent/WO2005073204A1/en active Application Filing
- 2005-01-18 KR KR1020087003065A patent/KR101008804B1/ko not_active IP Right Cessation
- 2005-01-18 AU AU2005207821A patent/AU2005207821B2/en not_active Ceased
- 2005-01-18 EA EA200900586A patent/EA016613B1/ru not_active IP Right Cessation
- 2005-01-18 JP JP2006551097A patent/JP4909086B2/ja not_active Expired - Fee Related
- 2005-01-18 KR KR1020067014630A patent/KR100849559B1/ko not_active IP Right Cessation
- 2005-01-18 CN CN2011101337521A patent/CN102250042A/zh active Pending
-
2006
- 2006-07-06 IL IL176738A patent/IL176738A0/en unknown
- 2006-07-19 CR CR8517A patent/CR8517A/es unknown
- 2006-07-19 EC EC2006006711A patent/ECSP066711A/es unknown
- 2006-08-18 MA MA29277A patent/MA28436B1/fr unknown
- 2006-08-22 NO NO20063760A patent/NO20063760L/no not_active Application Discontinuation
-
2011
- 2011-06-23 US US13/167,343 patent/US8217032B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2347973T3 (es) | 2010-11-26 |
US8217032B2 (en) | 2012-07-10 |
DE602005022673D1 (de) | 2010-09-16 |
ECSP066711A (es) | 2006-10-31 |
KR101008804B1 (ko) | 2011-01-14 |
AU2005207821A1 (en) | 2005-08-11 |
KR20060129277A (ko) | 2006-12-15 |
US20090023917A1 (en) | 2009-01-22 |
EA016613B1 (ru) | 2012-06-29 |
BRPI0506721A (pt) | 2007-05-02 |
MA28436B1 (fr) | 2007-02-01 |
UA85862C2 (uk) | 2009-03-10 |
EA200601353A1 (ru) | 2007-02-27 |
AU2005207821B2 (en) | 2011-02-10 |
EP1709021A1 (en) | 2006-10-11 |
JP4909086B2 (ja) | 2012-04-04 |
NO20063760L (no) | 2006-10-16 |
CA2551956C (en) | 2013-05-07 |
KR100849559B1 (ko) | 2008-07-31 |
JP2007519721A (ja) | 2007-07-19 |
US20110281847A1 (en) | 2011-11-17 |
EA200900586A1 (ru) | 2009-08-28 |
IL176738A0 (en) | 2006-10-31 |
EA012262B1 (ru) | 2009-08-28 |
CR8517A (es) | 2006-12-01 |
WO2005073204A1 (en) | 2005-08-11 |
EP1709021B1 (en) | 2010-08-04 |
CA2551956A1 (en) | 2005-08-11 |
KR20080016755A (ko) | 2008-02-21 |
CN102250042A (zh) | 2011-11-23 |
ATE476428T1 (de) | 2010-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG149867A1 (en) | Selective estrogen receptor modulators for the treatment of vasomotor symptoms | |
HK1097409A1 (en) | Azadecalin glucocorticoid receptor modulators | |
IL177982A0 (en) | Fused ring azadecalin glucocorticoid receptor modulators | |
TW200617019A (en) | A process for the preparation of 7α-alkylated 19-norsteroids | |
IL183543A0 (en) | Estrogen receptor modulators | |
IL182829A0 (en) | Estrogen receptor modulators | |
SG152239A1 (en) | Compounds for proteasome enzyme inhibition | |
GB0400440D0 (en) | Receptor modulators | |
WO2005105785A3 (en) | Indole derivatives for treatment of obesity | |
EP1813700A4 (en) | APPARATUS FOR THE PRODUCTION OF CRYSTALS | |
IL177957A0 (en) | Bazedoxifene ascorbate as selective estrogen receptor modulator | |
PL376803A1 (pl) | Nowe pochodne tetracykliczne zawierające heteroatomy, jako selektywne modulatory receptora estrogenowego | |
IL191710A0 (en) | Glucocorticoid receptor modulators as antiinflammatory agents | |
EP1895028A4 (en) | DEVICE FOR PRODUCING A SEMICONDUCTOR CRYSTAL | |
EP1733781A4 (en) | APPARATUS FOR CONCENTRATING METHANE GAS | |
DE602004014773D1 (de) | Pyrrol-2,5-dionderivate als modulatoren des liver-x-rezeptors | |
HK1070362A1 (en) | Non-steroidal progesterone receptor modulators | |
SG142306A1 (en) | Methods for neuroprotection | |
ZA200800690B (en) | Non-steroidal progesterone receptor modulators | |
EP1895029A4 (en) | DEVICE FOR PRODUCING A SEMICONDUCTOR MONOCRYSTAL | |
NO20091016L (no) | Pyridooksazepin-progesteron reseptormodulatorer | |
EP1680101A4 (en) | DEVELOPMENT OF NEW SELECTIVE OESTROGEN RECEPTOR MODULATORS | |
HUP0501174A2 (en) | Apparatus for introducing organwind | |
HK1096405A1 (en) | Progesterone receptor modulators | |
AU2008248873A8 (en) | New progesterone receptor modulators |